This inventor holds 2 USPTO granted patents. Top assignee: Dongwha Pharm. Ind. Co., Ltd.. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Ik Hoe Kim: Innovator in Antibacterial Compounds
Introduction
Ik Hoe Kim is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optically active compounds with antibacterial properties. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Ik Hoe Kim's latest patents focus on optically active quinoline carboxylic acid derivatives. These compounds are characterized by their 7-pyrrolidine substituents, which induce optical activity. The inventions detail a process for preparing these derivatives, which include their pharmaceutically acceptable salts and solvates. The compounds exhibit superior antibacterial activity and pharmacokinetic profiles compared to their enantiomers and conventional antibacterial agents, while also demonstrating minimal phototoxicity. This makes them promising candidates for use as antibacterial agents.
Career Highlights
Ik Hoe Kim is currently associated with Dongwha Pharm. Ind. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research has led to advancements in the development of effective antibacterial agents, contributing to the overall improvement of healthcare solutions.
Collaborations
Ik Hoe Kim has collaborated with notable colleagues, including Yoon Ho Jin and Chi Woo Lee. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Ik Hoe Kim's work in the field of optically active compounds showcases his dedication to advancing antibacterial treatments. His innovative patents and collaborations highlight his significant role in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile